First Manhattan’s Meridian Bioscience Inc VIVO Stock Holding History

First Manhattan’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,562	Closed	-$85.1K	–	1757
2022 Q4	$85.1K	Hold	2,562	–	–	﹤0.01%	858
2022 Q3	$80K	Hold	2,562	–	–	﹤0.01%	859
2022 Q2	$77K	Hold	2,562	–	–	﹤0.01%	891
2022 Q1	$66K	Hold	2,562	–	–	﹤0.01%	956
2021 Q4	$52K	Hold	2,562	–	–	﹤0.01%	992
2021 Q3	$49K	Hold	2,562	–	–	﹤0.01%	1000
2021 Q2	$56K	Hold	2,562	–	–	﹤0.01%	966
2021 Q1	$67K	Hold	2,562	–	–	﹤0.01%	900
2020 Q4	$47K	Hold	2,562	–	–	﹤0.01%	919
2020 Q3	$43K	Hold	2,562	–	–	﹤0.01%	902
2020 Q2	$59K	Sell	2,562 -2,700	-51%	-$39.1K	﹤0.01%	851
2020 Q1	$44K	Hold	5,262	–	–	﹤0.01%	870
2019 Q4	$51K	Hold	5,262	–	–	﹤0.01%	914
2019 Q3	$49K	Hold	5,262	–	–	﹤0.01%	917
2019 Q2	$62K	Hold	5,262	–	–	﹤0.01%	894
2019 Q1	$92K	Sell	5,262 -1,800	-25%	-$29.9K	﹤0.01%	843
2018 Q4	$122K	Hold	7,062	–	–	﹤0.01%	766
2018 Q3	$105K	Hold	7,062	–	–	﹤0.01%	839
2018 Q2	$112K	Sell	7,062 -500	-7%	-$7.46K	﹤0.01%	802
2018 Q1	$107K	Buy	7,562 +562	+8%	+$8.32K	﹤0.01%	791
2017 Q4	$98K	Hold	7,000	–	–	﹤0.01%	856
2017 Q3	$100K	Hold	7,000	–	–	﹤0.01%	807
2017 Q2	$110K	Hold	7,000	–	–	﹤0.01%	777
2017 Q1	$96K	Hold	7,000	–	–	﹤0.01%	819
2016 Q4	$123K	Hold	7,000	–	–	﹤0.01%	760
2016 Q3	$135K	Hold	7,000	–	–	﹤0.01%	745
2016 Q2	$136K	Hold	7,000	–	–	﹤0.01%	748
2016 Q1	$144K	Hold	7,000	–	–	﹤0.01%	722
2015 Q4	$143K	Hold	7,000	–	–	﹤0.01%	731
2015 Q3	$119K	Hold	7,000	–	–	﹤0.01%	770
2015 Q2	$130K	Hold	7,000	–	–	﹤0.01%	774
2015 Q1	$133K	Hold	7,000	–	–	﹤0.01%	776
2014 Q4	$115K	Hold	7,000	–	–	﹤0.01%	808
2014 Q3	$123K	Hold	7,000	–	–	﹤0.01%	777
2014 Q2	$144K	Hold	7,000	–	–	﹤0.01%	744
2014 Q1	$152K	Hold	7,000	–	–	﹤0.01%	720
2013 Q4	$185K	Hold	7,000	–	–	﹤0.01%	681
2013 Q3	$165K	Sell	7,000 -700	-9%	-$16.3K	﹤0.01%	694
2013 Q2	$186K	Buy	+7,700	New	+$166K	﹤0.01%	675

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First Manhattan's VIVO Position: Q1 2023 in Review

First Manhattan sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,562 shares — an estimated $85.1K sold.

First Manhattan first reported a position in VIVO in Q2 2013 and held it in 39 quarters. The position peaked at $186K in Q2 2013. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

First Manhattan reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
First Manhattan sold 2,562 Meridian Bioscience Inc shares in Q1 2023, an estimated $85.1K.
First Manhattan first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 39 quarters.
First Manhattan's Meridian Bioscience Inc position peaked at $186K in Q2 2013.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.